article thumbnail

Case Study: Two Examples of Successful Automation Integration at Altasciences for Pharmacokinetic Studies

Alta Sciences

He began his career in academia, focusing on plant epigenetics and molecular biology in Paris, France. In 2023, he relocated to Montreal, with the aim to continue automating tasks with the same liquid handling system, which ultimately led him to join Altasciences.

article thumbnail

Time for change: non-human primates in drug research

Drug Target Review

Federal ruling on USDA primate welfare petition, 2023. In the future, the most effective and ethical research won’t rely on tradition – it will be driven by technology, transparency and trust. References Animal Legal Defense Fund v. USDA (2020). National Research Council. Guide for the Care and Use of Laboratory Animals. Bailey J, et al.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Altasciences at ASGCT 2025: An Open Forum for All Things Gene and Cell Therapy | By Kaylyn Koenig

Alta Sciences

I also walked attendees through some of our DNA and RNA isolation techniques and our molecular biology laboratory’s experience in collecting samples and isolating genetic material to assess germline integration after preclinical studies. It was exciting to see how much interest the poster generated.

article thumbnail

Automated red blood cell exchange: bridging treatment gaps in sickle cell disease care

Drug Target Review

5,6 The 2023 approval of two engineered stem cell-based therapies marked a significant advancement, though these options require careful consideration of potential adverse events and long-term safety, 7 and access will remain a challenge for the foreseeable future. Updated 2023 Sep 4]. 2023 Jul 11;7(13):3276-3283. 2022009202.

Disease 52
article thumbnail

A Visual Guide to Genome Editors

Codon

The treatment, now known as Casgevy, became the first CRISPR-based therapy to gain FDA approval, in 2023. in late 2023 to treat the genetic blood disorders sickle cell anemia and beta thalassemia. A 2023 study found that individual off-target insertions caused by prime editing happen at frequencies of less than 1 percent each.

DNA 83
article thumbnail

Levers for Biological Progress

Codon

I’ve chosen these two because I think they are the linchpin by which we’ll be able to build broadly useful AI models for cell and molecular biology. But looking ahead to the second bottleneck, what does it mean to say that biology is “complex”? bioRxiv (2023). Credit: Shaib A.H.

DNA 133
article thumbnail

Scientists discover network of cells and genes involved in Crohn’s disease complication

Broad Institute

Isselbacher Professor of Medicine at Harvard Medical School, and director of the Center for Computational and Integrative Biology and core member in the Department of Molecular Biology at Massachusetts General Hospital. Lingjia Kong, a research scientist in the Xavier lab, is the first author on the study.

Disease 111